Session Information
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: Yao Syndrome (YS) is a systemic autoinflammatory disease formerly termed Nucleotide-binding oligomerization domain 2 (NOD2)-associated AutoInflammatory Disease (NAID) due to its association with specific genetic variants in NOD2. This study examined the function of NOD2 in YS patients.
Methods:
Study subjects (10 YS patients and 5 healthy individuals) were screened for NOD2 variants by sequencing or TaqMan probes. Plasma cytokine levels, NOD2 expression, and transcript splicing were measured by ELISA, qRT-PCR, and PCR, respectively. Functional assays were performed with peripheral blood mononuclear cells to assess NOD2activation in response to its ligand, muramyl dipeptide. The efficacy of tocilizumab therapy was examined in a YS patient.
Results: All YS patients were heterozygous for the NOD2 IVS8+158 variant and 4 were compound heterozygous for R702W. Plasma levels of TNFα, IL-1β, IFNγ, and S100A12 were unaltered in YS patients as compared to healthy individuals. Splicing of intron 8 was unaffected by carriage of the IVS8+158 variant; however, NOD2 expression was elevated in IVS8+158 heterozygous patients but not in IVS8+158/R702W compound heterozygotes. MDP-stimulated NFκB activity was suppressed uniquely in compound heterozygotes and correlated with lower TNFα secretion. IL-6 secretion was enhanced specifically in IVS8+158 heterozygotes and anti-IL6 receptor antibody (tocilizumab) treatment of a YS patient with this NOD2 genotype resulted in significant clinical improvement.
Conclusion:
Our findings indicate that YS is associated with dysfunction of NOD2, and specific NOD2 genotypes associate with distinct functional subtypes. This study suggests that NOD2 genotype could be used as a biomarker in the selection of therapeutic modalities for YS and warrants further investigation in clinical trials.
To cite this abstract in AMA style:
McDonald C, Shen M, Kabi A, Homer C, Yao Q. Functional Consequences of NOD2 Gene Variants in Patients with NOD2-Associated Autoinflammatory Disease [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/functional-consequences-of-nod2-gene-variants-in-patients-with-nod2-associated-autoinflammatory-disease/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/functional-consequences-of-nod2-gene-variants-in-patients-with-nod2-associated-autoinflammatory-disease/